pred
A corticosteroid related to prednisone and prednisolone.
- Drugs containing pred: 73
- Approved somewhere: 37
- With a US drug page: 33
- Stem
- pred
- Class
- Corticosteroids related to prednisone and prednisolone
- Sub-stems
- -betasol, -met(h)asone, -olone
- Most common targets
- NR3C1 (40), AR (6), GABA-A receptor; anion channel (3), NFE2L2 (1), NR3C2 (1), HSD11B1, HSD11B2 (1), PPARG (1), IKBKB (1)
Approved and clinical-stage drugs in ChEMBL whose names containing pred or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Difluprednate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Loteprednol etabonate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Prednicarbate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Prednisone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Meprednisone | Phase 2 | NR3C1 | Glucocorticoid receptor agonist |
| Fluprednisolone | — | NR3C1 | Glucocorticoid receptor agonist |
| Prednisolone tebutate | — | NR3C1 | Glucocorticoid receptor agonist |
| Methylprednisolone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Methylprednisolone acetate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Methylprednisolone hemisuccinate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Prednisolone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Prednisolone acetate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Prednisolone phosphoric acid | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Etiprednol dicloacetate | Phase 2 | — | — |
| Prednimustine | Phase 2 | — | — |
| Prednylidene | Phase 2 | — | — |
| Clobetasol propionate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Halobetasol propionate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Clobetasol | Phase 3 | — | — |
| Alclometasone dipropionate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone dipropionate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone valerate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Desoximetasone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Mometasone furoate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone benzoate | — | NR3C1 | Glucocorticoid receptor agonist |
| Flumethasone pivalate | — | NR3C1 | Glucocorticoid receptor agonist |
| Paramethasone acetate | — | NR3C1 | Glucocorticoid receptor agonist |
| Beclomethasone dipropionate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone acetate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Betamethasone phosphoric acid | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Dexamethasone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Dexamethasone acetate | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Dexamethasone phosphoric acid | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Mometasone | Phase 3 | — | — |
| Brexanolone | Approved | GABA-A receptor; anion channel | GABA-A receptor; anion channel positive allosteric modulator |
| Fluocinolone acetonide | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Ganaxolone | Approved | GABA-A receptor; anion channel | GABA-A receptor; anion channel positive allosteric modulator |
| Omaveloxolone | Approved | NFE2L2 | Nuclear factor erythroid 2-related factor 2 activator |
| Rimexolone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Triamcinolone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Triamcinolone acetonide | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Triamcinolone hexacetonide | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Vamorolone | Approved | NR3C1, NR3C2 | Glucocorticoid receptor agonist |
| Zuranolone | Approved | GABA-A receptor; anion channel | GABA-A receptor; anion channel positive allosteric modulator |
| Nandrolone decanoate | Phase 2 | AR | Androgen Receptor agonist |
| Clocortolone pivalate | — | NR3C1 | Glucocorticoid receptor agonist |
| Dromostanolone propionate | — | AR | Androgen Receptor agonist |
| Nandrolone phenpropionate | — | AR | Androgen Receptor agonist |
| Oxymetholone | — | AR | Androgen Receptor agonist |
| Triamcinolone diacetate | — | NR3C1 | Glucocorticoid receptor agonist |
| Carbenoxolone | Approved | HSD11B1, HSD11B2 | 11-beta-hydroxysteroid dehydrogenase inhibitor |
| Fluocortolone | Approved | — | — |
| Fluorometholone | Approved | NR3C1 | Glucocorticoid receptor agonist |
| Bardoxolone methyl | Phase 3 | PPARG, IKBKB, KEAP1, NFE2L2 | Peroxisome proliferator-activated receptor gamma antagonist |
| Nandrolone | Phase 3 | — | — |
| Norethandrolone | Phase 3 | — | — |
| Oxandrolone | Phase 3 | AR | Androgen Receptor agonist |
| Tibolone | Phase 3 | — | — |
| Clorexolone | Phase 2 | — | — |
| Enoxolone | Phase 2 | — | — |
| Fenozolone | Phase 2 | — | — |
| Nandrolone cyclotate | Phase 2 | — | — |
| Posovolone | Phase 2 | — | — |
| Pregnenolone succinate | Phase 2 | — | — |
| Sepranolone | Phase 2 | — | — |
| Stanolone | Phase 2 | — | — |
| Tioxolone | Phase 2 | — | — |
| Pregnenolone | Phase 1 | — | — |
| Acetoxolone | — | — | — |
| Diflucortolone | — | — | Unknown |
| Fluorometholone acetate | — | NR3C1 | Glucocorticoid receptor agonist |
| Methandrostenolone | — | AR | Androgen Receptor agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO